CHE

MKT CAP:$6B

Chemed Corporation

Market Cap

$6B

Healthcare·Medical - Care Facilities·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$373.15-$50.64 (-11.95%)

Apr 22, 2026

Company Details

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates ...

CEO

Kevin J. McNamara

IPO Date

May 3, 1973

Website

www.chemed.com

Key Metrics TTM

Revenue

$2.5B

+2.1% YoY

Net Income

$260M

EPS (Diluted)

$18.36

Free Cash Flow

$377M

Revenue / Share

$185.78

Gross Margin

22.5%

Operating Margin

12.9%

Net Margin

10.2%

FCF Margin

14.8%

P/S

2.2x

P/E

21.5x

Earnings Reports

Q1 2026

Apr 13, 2026

NEW

$658M+1.6%EPS $4.85

FY 2025

Feb 27, 2026

$2.5B+4.1%EPS $18.42

Q4 2025

Feb 27, 2026

$639M-0.1%EPS $5.48

Q3 2025

Oct 31, 2025

$625M+3.1%EPS $4.46

Q2 2025

Jul 31, 2025

$619M+3.8%EPS $3.57

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 22	$531M	$194M	$92M
Q3 22	$526M	$180M	$81M
Q4 22	$547M	$197M	$81M
Q1 23	$560M	$189M	$73M
Q2 23	$554M	$180M	$70M
Q3 23	$565M	$202M	$87M
Q4 23	$586M	$228M	$111M
Q1 24	$589M	$204M	$72M
Q2 24	$596M	$206M	$88M
Q3 24	$606M	$210M	$92M
Q4 24	$640M	$234M	$114M
Q1 25	$647M	$216M	$95M
Q2 25	$619M	$185M	$68M
Q3 25	$625M	$181M	$75M
Q4 25	$639M	$206M	$101M
Q1 26	$658M	$0	$85M

Valuation

Quarter	P/S	P/E
Q2 22	2.6x	20.1x
Q3 22	2.6x	21.3x
Q4 22	2.6x	22.4x
Q1 23	2.6x	23.3x
Q2 23	2.6x	24.6x
Q3 23	2.5x	22.8x
Q4 23	2.5x	20.5x
Q1 24	2.4x	19.7x
Q2 24	2.4x	18.5x
Q3 24	2.3x	18.5x
Q4 24	2.3x	18.5x
Q1 25	2.2x	18.1x
Q2 25	2.2x	19.2x
Q3 25	2.2x	20.0x
Q4 25	2.2x	21.0x
Q1 26	2.2x	21.5x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 22	$57M	$44M
Q3 22	$52M	$39M
Q4 22	$100M	$82M
Q1 23	$60M	$43M
Q2 23	$132M	$116M
Q3 23	$29M	$17M
Q4 23	$109M	$97M
Q1 24	$85M	$72M
Q2 24	$78M	$66M
Q3 24	$91M	$77M
Q4 24	$165M	$152M
Q1 25	$33M	$19M
Q2 25	$139M	$123M
Q3 25	$83M	$66M
Q4 25	$134M	$117M
Q1 26	$88M	$71M

Capital Expenditures

Quarter	CapEx
Q2 22	$13M
Q3 22	$13M
Q4 22	$18M
Q1 23	$17M
Q2 23	$16M
Q3 23	$12M
Q4 23	$12M
Q1 24	$12M
Q2 24	$11M
Q3 24	$14M
Q4 24	$13M
Q1 25	$13M
Q2 25	$16M
Q3 25	$17M
Q4 25	$16M
Q1 26	$17M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 22	-0.2%	-4.6%
Q3 22	-2.3%	-0.0%
Q4 22	+1.0%	+5.1%
Q1 23	+5.6%	+10.5%
Q2 23	+4.2%	+10.2%
Q3 23	+7.2%	+7.2%
Q4 23	+7.2%	+2.0%
Q1 24	+5.2%	+6.1%
Q2 24	+7.6%	+4.8%
Q3 24	+7.4%	+7.6%
Q4 24	+9.2%	+10.9%
Q1 25	+9.8%	+6.8%
Q2 25	+3.8%	+8.5%
Q3 25	+3.1%	+7.0%
Q4 25	-0.1%	+2.4%
Q1 26	+1.6%	+3.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 22	$7M	1.4%
Q3 22	$5M	0.9%
Q4 22	$7M	1.3%
Q1 23	$8M	1.5%
Q2 23	$8M	1.5%
Q3 23	$5M	1.0%
Q4 23	$8M	1.3%
Q1 24	$9M	1.5%
Q2 24	$9M	1.5%
Q3 24	$6M	1.0%
Q4 24	$8M	1.3%
Q1 25	$9M	1.4%
Q2 25	$9M	1.5%
Q3 25	-$15M	-2.4%
Q4 25	$24M	3.7%
Q1 26	$1M	0.2%

OpEx Breakdown

Quarter	G&A	SG&A
Q2 22	$88M	—
Q3 22	$84M	—
Q4 22	$85M	—
Q1 23	$100M	—
Q2 23	$93M	—
Q3 23	$100M	—
Q4 23	$100M	—
Q1 24	$116M	—
Q2 24	$100M	—
Q3 24	$102M	—
Q4 24	$104M	—
Q1 25	$106M	—
Q2 25	$99M	—
Q3 25	$106M	—
Q4 25	—	$106M
Q1 26	—	$114M

Revenue Segments

Quarter	Segment Roto Rooter	Segment Vitas
Q1 25	$249M	$416M
Q3 25	$226M	$421M
Q4 25	$232M	$430M

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 22	$10M	$0	$10M
Q3 22	$8M	$0	$8M
Q4 22	$74M	$0	$74M
Q1 23	$58M	$0	$58M
Q2 23	$160M	$0	$160M
Q3 23	$173M	$0	$173M
Q4 23	$264M	$0	$264M
Q1 24	$313M	$0	$313M
Q2 24	$223M	$0	$223M
Q3 24	$238M	$0	$238M
Q4 24	$178M	$0	$178M
Q1 25	$174M	$0	$174M
Q2 25	$250M	$0	$250M
Q3 25	$130M	$0	$130M
Q4 25	$75M	$0	$75M
Q1 26	$17M	$0	$17M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 22	15M	-0.5%	-6.1%
Q3 22	15M	-0.5%	-5.0%
Q4 22	15M	+0.1%	-3.0%
Q1 23	15M	+0.4%	-0.5%
Q2 23	15M	+0.7%	+0.7%
Q3 23	15M	-0.1%	+1.1%
Q4 23	15M	+0.5%	+1.4%
Q1 24	15M	+0.5%	+1.5%
Q2 24	15M	-0.6%	+0.2%
Q3 24	15M	-1.1%	-0.8%
Q4 24	15M	-0.6%	-1.8%
Q1 25	15M	-1.5%	-3.7%
Q2 25	15M	-1.1%	-4.2%
Q3 25	15M	-0.5%	-3.6%
Q4 25	14M	-3.7%	-6.7%
Q1 26	14M	-2.3%	-7.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 22	$37.6K	14K
Q3 22	$37.2K	14K
Q4 22	$38.6K	14K
Q1 23	$39.5K	14K
Q2 23	$39.1K	14K
Q3 23	$39.8K	14K
Q4 23	$38.8K	15K
Q1 24	$39.1K	15K
Q2 24	$39.5K	15K
Q3 24	$40.2K	15K
Q4 24	$42.4K	15K
Q1 25	$42.9K	15K
Q2 25	$41.0K	15K
Q3 25	$41.4K	15K
Q4 25	$42.4K	15K
Q1 26	$43.6K	15K

Revenue / Employee